FaDu Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Head-Neck cancer cell lines

Organism

Human

Donor History

Hypopharyngeal squamous cell carcinoma

Growth Properties

Adherent

Growth Conditions

Culture medium: EMEM (MEM Eagle)

,

w: 2 mM L-Glutamine

,

w: 2.2 g/L NaHCO3

,

w: EBSS (Cytion article number 820100a). Supplements: Supplement the medium with 10% FBS and 1% NEAA. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/FaDu-Cells/305033

SKU: 305033 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

FaDu is a human cell line derived from a squamous cell carcinoma of the hypopharynx. Established from a tumor in an adult patient, FaDu cells are frequently used in medical research focusing on cancer biology, particularly in studies related to head and neck cancers. These cells exhibit epithelial morphology and are adherent in culture conditions. FaDu is known for its robust growth and is often employed in assays to understand cancer cell proliferation, response to therapeutic agents, and gene expression related to cancer progression and metastasis.

In scientific research, FaDu cells have been instrumental in examining the efficacy of radiotherapy and chemotherapy treatments, providing insights into cellular responses to DNA damage and repair mechanisms. The cell line has also been utilized in studies exploring molecular pathways involved in cancer, such as the EGFR signaling pathway, which is often altered in head and neck cancers. The versatility and relevance of FaDu cells make them a valuable model for oncology research, contributing to the development of targeted therapies and understanding cancer cell biology at a molecular level.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.